Prediction and optimisation of the acoustic performance of mufflers for sleep apnea devices. ResMed is a world leader in the technology of developing products for treating obstructive sleep apnea (OSA). ResMed provided the first successful non-invasive treatment of OSA with their sleep apnea device. Noise reduction is an important issue in the development of this product, since these devices operate on a bedside table. This project will enable the acoustic performance of these small irregularly ....Prediction and optimisation of the acoustic performance of mufflers for sleep apnea devices. ResMed is a world leader in the technology of developing products for treating obstructive sleep apnea (OSA). ResMed provided the first successful non-invasive treatment of OSA with their sleep apnea device. Noise reduction is an important issue in the development of this product, since these devices operate on a bedside table. This project will enable the acoustic performance of these small irregularly shaped mufflers to be reliably predicted and optimised. The successful outcomes will improve the quality of the well-being of the user. This research also has relevance to the design of mufflers for use in broader applications such as locomotives and ferries.Read moreRead less
Social Support Provided in China to Older People with Disabilities. The project contributes to understanding our region through the opportunity to demonstrate Australia's engagement with China, with which it is establishing strong links in social, economic and cultural interests. It contributes to national understanding of East Asian policies for older people with a disability, including partnership approaches to social support between government, non-government and communities. The project stre ....Social Support Provided in China to Older People with Disabilities. The project contributes to understanding our region through the opportunity to demonstrate Australia's engagement with China, with which it is establishing strong links in social, economic and cultural interests. It contributes to national understanding of East Asian policies for older people with a disability, including partnership approaches to social support between government, non-government and communities. The project strengthens connections between Australian researchers and policy officials, the China Research Centre on Ageing, and Chinese government organisations.Read moreRead less
New methods to improve regional isotope therapy of liver tumours in cancer patients. The most common cause of death in cancer patients is secondary tumours in vital organs. Successful treatment of liver tumours with regional isotope therapy now offers improved survival rates. This project will research novel radiolabelled nanoparticles and advanced computer imaging algorithms to improve regional isotope therapy of liver tumours. It will provide better methods of objective assessment and manageme ....New methods to improve regional isotope therapy of liver tumours in cancer patients. The most common cause of death in cancer patients is secondary tumours in vital organs. Successful treatment of liver tumours with regional isotope therapy now offers improved survival rates. This project will research novel radiolabelled nanoparticles and advanced computer imaging algorithms to improve regional isotope therapy of liver tumours. It will provide better methods of objective assessment and management that can reduce risk and improve patient survival.Read moreRead less
Central nervous system cytokines and morphine analgesia. Morphine remains the drug of choice for the management of moderate-to-severe pain, however its clinical effectiveness is compromised by the fact that morphine's analgesic (pain reducing) efficacy becomes less effective the more it is administered.. This project will examine how analgesic tolerance develops from a completely new approach: Namely, how stimulation of the immune system within the central nervous system is a crucial factor in t ....Central nervous system cytokines and morphine analgesia. Morphine remains the drug of choice for the management of moderate-to-severe pain, however its clinical effectiveness is compromised by the fact that morphine's analgesic (pain reducing) efficacy becomes less effective the more it is administered.. This project will examine how analgesic tolerance develops from a completely new approach: Namely, how stimulation of the immune system within the central nervous system is a crucial factor in the development of tolerance. Modulation of analgesia by the immune system has not been systematically studied and provides a potentially fertile ground for the development of new techniques in the management of clinical pain.Read moreRead less